INM · InMed Pharmaceuticals Inc. · Investor Relations
$1.33
-0.02 (-1.48%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Sep 9, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have concluded that there is substantial doubt about our ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.”View the 10-K filed Sep 9, 2026
Market Cap
$7.58M
Shares
5.49M
Volume · Oct 2
28.34K
Avg daily vol (3M)
916.81K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2025-12-11 | Life Sciences Virtual Investor Forum | Event |
| 2025-09-18 | InMed Presenting at Life Sciences Investor Forum | Event |
| 2024-11-12 | Fierce Biotech Webinar: Alzheimer’s Outlook – Neuroinflammation, the Next Step | Event |
| 2024-08-01 | Alzheimer’s Association International Conference® | Conference |
| 2024-06-20 | Benzinga Healthcare + Biotech Breakthroughs | Event |
| 2024-06-13 | Emerging Growth Conference | Conference |
| 2024-02-01 | The Microcap Conference 2024 | Conference |
| 2024-01-25 | Water Tower Research Fireside Chat with InMed CEO Eric A. Adams | Event |
| 2023-12-01 | MJ Biz Con | Event |
| 2023-11-07 | 12th World Congress on Itch (WCI) 2023 | Event |
| 2023-06-01 | Investor Summit | Event |
| 2023-05-31 | Tribe Public Webinar | Event |
| 2023-05-23 | Fireside Chat with Water Tower Research | Event |